Karyopharm Therapeutics (KPTI)
(Delayed Data from NSDQ)
$0.96 USD
+0.01 (1.43%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $0.97 +0.01 (1.01%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum D VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 38% (103 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.43 | 1.52 | 9.99 |
Current Quarter Estimate | -0.29 | -2.04 | 61.00 |
Year Ago Quarter Estimate | -0.29 | -0.59 | 54.84 |
Next Quarter Estimate | -0.27 | -2.00 | 63.00 |
Next Year Estimate | -0.80 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 7.20 | 13.40 | 15.67 |
Next Year | 31.03 | 16.00 | 9.31 |
Last 5 Years | NA | 7.00 | 8.10 |
Next 5 Years | NA | 25.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | NA | 1.82 |
Price/Cash Flow (MRFY) | NA | 8.53 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -104.18% | -315.56% |
Return on Equity (TTM) | NA | -82.03% |
Debt to Equity (MRQ) | NA | 0.04 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.